Activest Wealth Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
CB
BTW
CIM
RP
CFM
LKIM
PFSRSONJ
Activest Wealth Management's CRL Position: Q2 2026 in Review
Activest Wealth Management increased its Charles River Laboratories (CRL) stake by 33% in Q2 2026, buying an estimated $9.79K and bringing the position to 220 shares worth $49.9K. The position accounts for 0.01% of the portfolio, ranked #280.
Activest Wealth Management first reported a position in CRL in Q1 2025 and has held it in 6 quarters since. 154 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Activest Wealth Management held 220 shares of Charles River Laboratories worth $49.9K as of Q2 2026.
- Activest Wealth Management bought 55 Charles River Laboratories shares in Q2 2026, an estimated $9.79K.
- Charles River Laboratories made up 0.01% of Activest Wealth Management's portfolio in Q2 2026, its #280 holding.
- Activest Wealth Management first reported a position in Charles River Laboratories in Q1 2025 and has held it in 6 quarters since.
- 154 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.